The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -1,100,642 |
| Net revenue | 7,909,655 |
| Cost of goods sold | 7,125,144 |
| Gross profit | 784,511 |
| Distribution, selling, and administrative expenses | 782,789 |
| Acquisition-related charges and intangible amortization | 12,549 |
| Exit and realignment charges, net | 72,379 |
| Goodwill impairment charge | 106,389 |
| Loss on classification to held for sale | 798,934 |
| Other operating expense, net | -10,932 |
| Operating (loss) income | -999,461 |
| Interest expense, net | -36,001 |
| Other expense | 1,405 |
| Loss from discontinued operations before income taxes | -1,036,867 |
| Income tax benefit for discontinued operations | -38,907 |
| Loss from discontinued operations, net of tax | -997,960 |
| Depreciation and amortization | 214,524 |
| Share-based compensation expense | 12,873 |
| Deferred income tax benefit | -17,887 |
| Changes in operating lease right-of-use assets and lease liabilities | -735 |
| Gain from sale and dispositions of patient service equipment | 27,274 |
| Accounts receivable, net | -122,363 |
| Inventories | 6,854 |
| Accounts payable | 6,478 |
| Net change in other assets and liabilities | 56,779 |
| Other, net | -8,999 |
| Cash (used for) provided by operating activities from discontinued operations | -256,286 |
| Cash (used for) provided by operating activities | -101,790 |
| Proceeds from p&hs sale | 342,351 |
| Cash sold with p&hs sale | 18,091 |
| Additions to patient service equipment and other fixed assets | 190,956 |
| Proceeds from sale of patient service equipment | 77,968 |
| Additions to computer software | 10,369 |
| Other, net | 1,910 |
| Cash used for investing activities from discontinued operations | -54,570 |
| Cash provided by (used for) investing activities | 144,423 |
| Borrowings under revolving credit facility | 2,914,784 |
| Repayments under revolving credit facility | 2,711,284 |
| Repurchase of common stock | 10,179 |
| Other, net | -3,116 |
| Cash used for financing activities from discontinued operations | -2,127 |
| Cash provided by (used for) financing activities | 188,078 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,896 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 232,607 |
| Statement table | 0 |
| Cash, cash equivalents and restricted cash at end of period | 0 |
| Cash, cash equivalents and restricted cash at beginning of period | 49,382 |
| Cash, cash equivalents and restricted cash at end of period | 281,989 |
ACCENDRA HEALTH INC VA (ACH)
ACCENDRA HEALTH INC VA (ACH)